AstraZeneca PLC (AZN) Announces Positive Results From a Prespecified Interim Analysis of the I CAN Phase III Trial

1 day ago 1

Noor Ul Ain Rehman

Mon, April 27, 2026 astatine 1:05 AM CDT 2 min read

AstraZeneca PLC (NYSE:AZN) is 1 of the champion stem compartment therapy stocks to buy. AstraZeneca PLC (NYSE:AZN) announced connected April 21 that affirmative high-level results from a prespecified interim investigation of the I CAN Phase III proceedings showed that Ultomiris met its superior endpoint, exhibiting a statistically important and clinically meaningful simplification of proteinuria. This was based connected a 24-hour urine macromolecule creatinine ratio astatine week 34 successful adults with immunoglobulin A nephropathy (IgAN) who are astatine hazard of illness progression. Management stated that the superior endpoint of alteration from baseline successful estimated glomerular filtration complaint (eGFR) volition beryllium measured astatine week 106.

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built connected Innovation

AstraZeneca PLC (NYSE:AZN) besides reported that the information illustration observed successful the proceedings remained accordant with the known illustration of Ultomiris, with nary caller information concerns identified. According to the management, the institution volition question accelerated support successful cardinal markets and volition contiguous these results astatine a forthcoming aesculapian meeting. IgAN is simply a rare, inflammatory illness of the kidneys that tin effect successful chronic kidney illness (CKD) and advancement to end-stage kidney illness (ESKD).

AstraZeneca PLC (NYSE:AZN) is simply a biopharmaceutical institution that explores, develops, manufactures, and commercializes medicine medicines. It supplies its products and services to specialty and superior attraction physicians, and is progressive successful exploring caller immuno-oncology attraction approaches. AstraZeneca PLC (NYSE:AZN) distributes its products and services done section typical offices and distributors.

While we admit the imaginable of AZN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article